1 Bai Y, Zheng JE, Wang N, et al. Effects of dendritic cell-activated and cytokine-induced killer cell therapy on 22 children with acute myeloid leukemia after chemotherapy. J Huazhong Univ Sci Technolog Med Sci, 2015, 35(5): 689-693. doi: 10.1007/s11596-015-1491-5.
2 Zhao X, Ji CY, Liu GQ, et al. Immunomodulatory effect of DC/CIK combined with chemotherapy in multiple myeloma and the clinical efficacy. Int J Clin Exp Pathol, 2015, 8(10): 13146-13155.
3 Lan XP, Chen YG, Wang Z, et al. Immunotherapy of DC-CIK cells enhances the efficacy of chemotherapy for solid cancer: a meta-analysis of randomized controlled trials in Chinese patients. J Zhejiang Univ Sci B, 2015, 16(9): 743-756. doi: 10.1631/jzus.B1500003.
4 Schmidt-Wolf IG, Lefterova P, Johnston V, et al. Sensitivity of multidrug-resistant tumor cell lines to immunologic effector cells. Cell Immunol, 1996, 169(1): 85-90. doi:10.1006/cimm.1996.0094.
5 Tuyaerts S, Meirvenne SV, Bonehill A, et a1. Expression of human GITRL on myeloid dendritic cells enhances their immunostimulatory function but does not abrogate the suppressive effect of CD4+CD25+ regulatory T cells. Journal of Leukocyte Biology, 2007, 82(1): 93-105. doi: 10.1189/jlb.0906568.
6 Cheng XY, Li JL. Biological activity of cytotoxic dendritic cells cocultured with cytokine-induced killer cells and their effect on acute leukemia cells. Genet Mol Res, 2015, 14(4): 13208-13214. doi: 10.4238/2015.october.26.
7 Li H, Wang C, Yu J, et al. Dendritic cell-activated cytokine-induced killer cells enhance the anti-tumor effect of chemotherapy on non-small cell lung cancer in patients after surgery. Cytotherapy, 2009, 11(8): 1076-1083. doi: 10.3109/14653240903121252.
8 Cui Y, Yang X, Zhu W, et al. Immune response, clinical outcome and safety of dendritic cell vaccine in combination with cytokine-induced killer cell therapy in cancer patients. Oncol Lett, 2013, 6(2):537-541. doi: 10.3892/ol.2013.1376.
9 Wang S, Wang Z. Efficacy and safety of dendritic cells co-cultured with cytokine-induced killer cells immunotherapy for non-small-cell lung cancer. Int Immunopharmacol, 2015, 28(1): 22-28. doi: 10.1016/j.intimp.2015.05.021.
10 Gong XJ, Liu JQ, Li Xi, et al. Clinical observation of co-treatment with autologous CIK cells and dendritic cells for postoperative advanced gastric carcinoma. Chin J Clin Oncol, 2007, 34(14): 803-806.
11 Yang L, Ren B, Li H, et al. Enhanced antitumor effects of DC-activated CIKs to chemotherapy treatment in a single cohort of advanced non-small-cell lung cancer patients. Cancer immunol immunother, 2013, 62(1): 65-73. doi: 10.1007/s00262-012-1311-8.
12 Yuanying Y, Lizhi N, Feng M, et al. Therapeutic outcomes of combining cryotherapy, chemotherapy and DC-CIK immunotherapy in the treatment of metastatic non-small cell lung cancer. Cryobiology, 2013, 67(2): 235-240. doi: 10.1016/j.cryobiol.2013.08.001.
13 Zhao X, Ding HF, Xu M, et al. Clinical efficacy of dendritic cells and cytokine-induced killer cells combined with chemotherapy for treating newly diagnosed multiple myeloma and their effect on function of CD4(+) CD25(+) T cells in peripheral blood. J Exper Hemat, 2016, 24(1): 122-126.
14 Zheng C, Yu G, Wang H, et al. Meta-analysis of chemotherapy and dendritic cells with cytokine-induced killer cells in the treatment of non-small-cell lung cancer. Int J Clin Exp Med, 2015, 8(8): 14527-14537.